We have a unique CRO profile providing unique and innovative dual expertise combining clinical research implementation with the development of customized IT applications specific to the pharmaceutical industry.
Launch of Astrum CRO
8 November 2023 We’re proud and very excited to introduce the brand new CRO, Astrum!Our strong and established European CRO’s Bioclever, Blueclinical, Pharmalog and Popsicube havejoined forces with the support of Henko Partners to form Astrum, a mid-size pan-European CRO.Astrum will provide a broad range of end-to-end clinical development services through a dynamicteam of highly […]
ADDITIV Médical France – 26 january 2021
Popsicube has participated to the virtual show dedicated to 3d printing in the medical field. For more information : https://www.additiv.events/medical-france?cid=bb68415b-ae2c-434a-a229-379aeb895955
Mission TEC will be present at the 1st edition of the Summer Health Campus
Mission TEC, a division of POPSICUBE, will be present on Thursday 6 and Friday 7 June 2019 at the 1st edition of the Summer Health Campus which will take place in Toulouse. On the schedule: conferences on the medicine of the future, the impact of sport on health as well as a debate on the […]
Discover Fabrice BEAUCHÊNE’s interview in the TV78 news
On 2019 April the 24th , M. Fabrice BEAUCHÊNE, Founder and Chairman of POPSICUBE, was invited by the Yvelines television channel TV78 to talk about the recent opening of a Russian affiliate to continue its international expansion. Credits : TV78 – La chaîne des Yvelines
PopsiCube acquires FOVEA Group CRO
PARIS, France – June 1st, 2017 – POPSICUBE sarl, offering efficient and innovative clinical, and consulting services to the healthcare industry, today announced it has completed the acquisition of FOVEA SAS, a recognized French leader of drug development services to the pharmaceutical, biotechnology, and medical device industries. Financial terms of the transaction were not disclosed. […]
